Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Clovis Oncology Inc (CLVS)

58.37 +1.45 (+2.55%)

4/25/2017  12:16pm

Open:

57.31

Pre. Close:

56.92

High:

59.46

Low:

57.31

Volume:

674,491

Market Cap:

2.60B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

57.48 - 58.93

58.93 - 59.92

Low:

52.08 - 53.07

53.07 - 53.74

Close:

55.27 - 57.44

57.44 - 58.92

Technical analysis  (as of: 2017-04-25 12:01:37 PM)

Overall:

      

Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 75.64     One year: 84.06

Support:

Support1: 53.10    Support2: 44.18

Resistance:

Resistance1: 64.76    Resistance2: 71.97

Pivot:

56.35

Moving Averages:

MA(5): 55.81     MA(20): 58.20

MA(100): 55.51     MA(250): 35.63

MACD:

MACD(12,26): -1.90     Signal(12,26,9): -1.97

%K %D:

%K(14,3): 32.91     %D(3): 22.16

RSI:

RSI(14): 48.28

52-Week:

High: 74.94  Low: 11.57  Change(%): 310.9

Average Vol(K):

3-Month: 1875  10-Days 1216

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CLVS has closed below upper band by 27.2%. Bollinger Bands are 35.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 08 Sep 2016 17:21:15 GMT
Why Clovis Oncology Inc. Is Soaring Today

Mon, 19 Dec 2016 17:20:12 GMT
Clovis Oncology spikes; receives early FDA approval for advanced cancer drug

Thu, 20 Apr 2017 12:04:15 GMT
Clovis Oncology to Announce First Quarter 2017 Financial Results and Host ...

Tue, 25 Apr 2017 03:22:30 GMT
Clovis Oncology Inc (CLVS) Given a $77.00 Price Target at Piper Jaffray Companies

Mon, 10 Oct 2016 16:41:11 GMT
Why Clovis Oncology Inc. Rose 52.7% in September

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

44.63

Shares Float (M)

31.02

% Held by Insiders

10.02

% Held by Institutions

84.30

Shares Short (K)

7670

Shares Short Prior Month (K)

7810

Stock Financials

EPS

-9.070

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

-0.090

PEG Ratio

-0.35

Profit Margin

Operating Margin

-374169.22

Return on Assets (ttm)

-33.8

Return on Equity (ttm)

-235.1

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

0.002

EBITDA (p.s.)

-6.514

Qtrly Earnings Growth

Operating Cash Flow (M)

-266.68

Levered Free Cash Flow (M)

-157.59

FoxReading.com

Valuation

P/E

-6.41

P/E Growth Ratio

0.02

P/BV

-646.44

P/S

33289.40

P/CF

-9.74

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.